Details of the Drug
General Information of Drug (ID: DM6Y2KW)
| Drug Name |
3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile; CHEMBL577938; SMR000054390; AC1LCDQ5; Cambridge id 5105969; MLS000104455; cid_625239; ZINC28097; SLQVQKSDEBBOSA-UHFFFAOYSA-N; MolPort-000-475-780; HMS1700M17; BDBM50303384; STK831931; AKOS000663950; MCULE-3002689151; BAS 13070166; ST001263; AB00073722-01; 3-Amino-5-furan-2-yl-biphenyl-2,4-dicarbonitrile; 2-amino-6-(2-furyl)-4-phenylbenzene-1,3-dicarbonitrile; 1,1'-Biphenyl-2,4-dicarbonitrile, 3-amino-5-(2-furyl)-; 3-Amino-5-(2-furyl)[1,1'-biphenyl]-2,4-dicarbonitrile #
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 285.3 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


